Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
Thermo Fisher Scientific completed the sale of its microbiology business to Astorg for approximately $1.075 billion, consisting of cash and a seller note. The divested unit, part of the Specialty Diagnostics segment, generated $645 million in revenue in 2025 and provides antimicrobial susceptibility testing solutions.
Key figures
- Deal Value Usd
- 1075000000
- Seller note
- 50000000
- Divestiture revenue 2025
- 645000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.